|1.||McDonough, J H: 3 articles (02/2003 - 01/2000)|
|2.||Hirose, S: 3 articles (02/2001 - 01/2000)|
|3.||Caro, S T: 2 articles (02/2003 - 02/2002)|
|4.||Byers, C E: 2 articles (02/2003 - 02/2002)|
|5.||Capacio, B R: 2 articles (02/2003 - 02/2002)|
|6.||Kassa, J: 2 articles (01/2001 - 11/2000)|
|7.||Shih, T M: 2 articles (05/2000 - 01/2000)|
|8.||Fujimori, Haruo: 1 article (06/2015)|
|9.||Mashiko, Hirobumi: 1 article (06/2015)|
|10.||Kanno, Tomoyuki: 1 article (06/2015)|
|1.||Parkinsonian Disorders (Parkinsonism)
01/01/2014 - "With a diagnosis of drug-induced Parkinsonism, he was started on 4-mg/day biperiden leading to full resolution of symptoms in 4 weeks, with no further complaints at follow up for 1.5 years. "
10/01/2003 - "Consequently, the cardiac autonomic function was not affected by biperiden or the change in parkinsonism. "
10/01/2003 - "Biperiden was discontinued in 33 patients with or without parkinsonism and commenced in 15 patients with parkinsonism. "
01/01/2003 - "Our patient is the third case of parkinsonism developing after an acute severe cholinergic crisis and the first case successfully treated with biperiden. "
04/01/1964 - "THE USE OF AKINETON FOR PARKINSONISM."
|2.||Psychomotor Agitation (Akathisia)
01/01/2000 - "These results suggest that i.v. administration of 5 mg of biperiden could be used to provide a rapid and effective treatment for patients with severe akathisia."
01/01/2000 - "It has been shown that intramuscular biperiden is a relatively rapid and effective treatment for akathisia. "
06/01/2007 - "The effectiveness of intramuscular biperiden in acute akathisia: a double-blind, randomized, placebo-controlled study."
05/01/2000 - "One previous study found brisk decrements in psychopathology after acute treatment of akathisia with intramuscular biperiden. "
02/01/2001 - "The restlessness ceased with intramuscular biperiden and subsequent discontinuation of antipsychotic medication. "
07/01/2003 - "After biperiden was administered, her abnormal movements markedly decreased; later, they almost completely disappeared. "
08/01/1992 - "Four cases of respiratory dyskinesia were investigated by using a spirograph before and after biperiden injection. "
11/01/2006 - "The dyskinesia was treated successfully with Biperiden 5 mg i. v. Tardive dyskinesia is a potential and in rare cases irreversible complication of MCP-therapy. "
02/01/1987 - "In 9 patients extrapyramidal symptoms were observed (6 parkinsonism, 2 early dyskinesia, 1 parkinsonism and early dyskinesia), which required sporadic (n = 3) or continuous (n = 2) treatment with biperiden in 5 cases. "
07/01/2003 - "In conclusion, we would like to emphasize that severe dyskinesia can be observed during phenytoin therapy and that biperiden can be successfully used in the treatment of this unpleasant condition."
|4.||Dystonia (Limb Dystonia)
06/01/1995 - "Therapeutic measures were gastric emptying in 32% of cases, biperiden when dystonia was present but only after consultation with the Centre and with 12-14 hours delay, and supportive treatment in all symptomatic patients."
12/01/1994 - "Twenty-three patients developed dystonia, two of them despite being treated with biperiden. "
01/01/1991 - "We studied the effect of biperiden in the treatment of dystonia in six patients aged 15-30 years. "
01/01/1991 - "High dose anticholinergic therapy (biperiden) in dystonia."
01/01/1990 - "Doses of 5 mg of biperiden reduced dystonia when evaluated by total scores, global scores, and subjective scores. "
|5.||Schizophrenia (Dementia Praecox)
01/15/2011 - "The aim of this study was to evaluate the effects of gradual discontinuation of biperiden, an anticholinergic drug, on cognitive function and quality of life (QOL) in schizophrenia. "
09/01/1979 - "The study reports about the intravenous application of Biperiden at patients with acute hypokinetic reaction suffering from schizophrenia of the paranoid-hallucinatory type. "
01/15/2011 - "Discontinuation of long-term biperiden use may be warranted in patients with schizophrenia treated with SGAs, as it may improve cognitive function, subjective QOL, and psychiatric symptoms with no significant adverse effects."
01/15/2011 - "To compare the practice effect on BACS-J, 10 chronic patients with schizophrenia were assessed without tapering biperiden. "
01/15/2011 - "Before and 4 weeks after discontinuation of biperiden, the Japanese version of the Brief Assessment of Cognition in Schizophrenia (BACS-J) and the Schizophrenia Quality of Life Scale (SQLS-J) were administered. "